Axon Enterprise (AXON) Prices $1B of Zero-Coupon Notes. What is the Real Cost?

by | Sep 20, 2026 | Stock Market

Axon Enterprise (AXON) Prices $1B of Zero-Coupon Notes. What is the Real Cost?

Axon Enterprise announced pricing of $1 billion in zero-coupon convertible senior notes on September 16, with settlement expected on September 18. Underwriters also received an option to purchase an additional $150 million to cover over-allotments.

After underwriting discounts and estimated offering expenses, Axon expects to retain approximately $986 million in gross proceeds. The company incurred $99.9 million in capped-call transactions, leaving approximately $886.1 million available for general corporate purposes, which may include acquisitions and investments. These calculations exclude any exercise of the additional-note option.

The zero-coupon structure differs from conventional debt by eliminating regular interest payments during the financing period, preserving cash that would otherwise flow to creditors. The principal amount remains fixed and does not accrue interest over time. The initial conversion rate stands at 1.5336 shares per $1,000 principal, equivalent to approximately $652.06 per share. Axon retains flexibility to settle conversions through cash, shares, or a combination thereof.

Axon entered into capped-call transactions with an initial cap price of $1,049.94, designed to reduce dilution from conversion or offset cash payments above the principal amount. The cap price remains subject to adjustments. Note holders possess a repurchase right on March 20, 2031, prior to maturity on September 15, 2031. Axon may use shares to settle repurchases only under specified circumstances and subject to maximum share limitations, with any excess payable in cash.

The company has not designated the proceeds for specific projects, instead identifying broad uses encompassing acquisitions and expansion efforts. The financing structure presents a trade-off between near-term cash preservation and future settlement obligations, with investment returns ultimately determining whether the capital deployment generates shareholder value. Hedge fund holdings in Axon declined to 53 funds by the end of the second quarter, down from 59 funds three months earlier, according to available filings.

Article Attribution | Read More at Article Source

Article summary produced by Claude AI